- 期刊
Decreased Risk of Squamous Cell Carcinoma of the Head and Neck in Users of Nonsteroidal Anti-Inflammatory Drugs
延伸閱讀
- Knauer, S. K. (2009). Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas. Journal of Oncology, 2009(), 312-321. https://doi.org/10.1155/2009/349205
- 林群書（2019）。Investigation of molecular mechanism of Ovatodiolide in the treatment of head and neck squamous cell carcinoma〔博士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-1401201907344700
- 王宏銘、廖俊達、范網行、吳樹鏗、詹勝傑、閣紫宸（2009）。Recent Advances and New Standards of Care for Patients with Head and Neck Squamous Cell Carcinoma。腫瘤護理雜誌，9(S)，51-67。https://doi.org/10.6880/TJON.200912/SP_9.05
- Hsu, M. L., Lee, J. C., Liu, C. J., Chen, Y. J., Chang, Y. F., & Leu, Y. S. (2021). Analysis of De Novo and Radiation-Induced Sarcomatoid Carcinoma of Head and Neck: A Single-Center Experience. International Journal of Head and Neck Science, 5(3), 105-110. https://doi.org/10.6696/IJHNS.202109_5(3).0003
- Shaib, W., Kono, S., & Saba, N. (2012). Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck. Journal of Oncology, 2012(), 522-532-055. https://doi.org/10.1155/2012/521215